Yanxiao Zhang Selected Research

Small Interfering RNA (siRNA)

1/2020

Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanxiao Zhang Research Topics

Disease

5	Neoplasms (Cancer) 01/2020 - 01/2016
3	Genetic Translocation (Chromosomal Translocation) 01/2017 - 12/2015
3	Thyroid Neoplasms (Thyroid Cancer) 01/2017 - 12/2015
2	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2018
1	Heart Failure 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Urogenital Neoplasms 01/2018
1	Follicular Adenocarcinoma 01/2017
1	Carcinogenesis 12/2015

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2015
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 12/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 12/2015
2	Pioglitazone (Actos)FDA Link 01/2017 - 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Androgen Antagonists (Antiandrogens)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2018
1	LigandsIBA 01/2017
1	Thyroid Nuclear Factor 1IBA 01/2016
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2016

Therapy/Procedure

1	Therapeutics 01/2020